Cite
Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV.
MLA
Chen, Xin-xin, et al. “Efficacy of a Live Attenuated Highly Pathogenic PRRSV Vaccine against a NADC30-like Strain Challenge: Implications for ADE of PRRSV.” BMC Veterinary Research, vol. 17, no. 1, July 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12917-021-02957-z.
APA
Chen, X., Zhou, X., Guo, T., Qiao, S., Guo, Z., Li, R., Jin, Q., Hu, X., Xing, G., Deng, R., Wan, B., & Zhang, G. (2021). Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV. BMC Veterinary Research, 17(1), 1–11. https://doi.org/10.1186/s12917-021-02957-z
Chicago
Chen, Xin-xin, Xinyu Zhou, Tengda Guo, Songlin Qiao, Zhenhua Guo, Rui Li, Qianyue Jin, et al. 2021. “Efficacy of a Live Attenuated Highly Pathogenic PRRSV Vaccine against a NADC30-like Strain Challenge: Implications for ADE of PRRSV.” BMC Veterinary Research 17 (1): 1–11. doi:10.1186/s12917-021-02957-z.